Renoprotective Effects of Empagliflozin Plus Liraglutide vs Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial
Diabetes Care 2021 Aug 06;[EPub Ahead of Print], RV Cohen, TBZ Petry, AD Miras, CM Aboud, B Johnson, TM Dos Santos, CW le RouxFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.